Write For Us

Merck eyes $40 billion deal for biotech Seagen, report says

Sponsored Post Vitamin D2 Canada Persia
20 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Drugmaker Merck is in advanced talks to buy cancer-focused biotech company Seagen in a deal that could be worth $40 billion or more, the Wall Street Journal reports.

#News #Reuters #Merck #drugmaker #Seagen #deal

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Category
World
Tags
reuters, news, top news
Sign in or sign up to post comments.
Be the first to comment